Cardioptimus
Innovative embolic deflection device enhances patient outcomes in cardiac procedures, mitigating stroke risks during transcatheter aortic valve replacement.
General Information
BounceWatch is an independent company data service, not affiliated with Cardioptimus. To contact Cardioptimus, visit cardioptimus.weebly.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Cardioptimus compare?
A PDF of Cardioptimus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Cardioptimus soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Cardioptimus
Business keywords: Cardiac surgery, Medical devices, Innovation, Embolic deflection device, Transcatheter aortic valve replacement, Neurological issues, Stroke prevention, Patient outcomes, Medical innovations
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | $150.00K | 1 |
-logo.jpg){kind=logo}
|
15 Dec 2014 |
Cardioptimus Alternatives & Competitors
View All Alternatives
Point-Guard Protected™ Stroke Matters. Safeguard the Brain, Treat the Heart.
Addressing unmet needs in structural heart disease, vascular therapy and urology.
FAQ About Cardioptimus
Source: BounceWatch company record for Cardioptimus, https://bouncewatch.com/company/cardioptimus, updated 26 December 2024. When citing, please name BounceWatch and link this page.
